Clinical trial
A Phase I Study of Depsipeptide in Selected Hematologic Malignancies (NSC 630176)
NCT00024180 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of Depsipeptide in Selected Hematologic Malignancies (NSC 630176)
- Lead sponsor
- Ohio State University Comprehensive Cancer Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2002
- Completion date
- August 31, 2006
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.